Search results
BIIB Investors Have Opportunity to Lead Biogen Inc. Securities Fraud Lawsuit
FOX 23 News Albany· 7 days ago("Biogen" or the "Company") (NASDAQ: BIIB). Class Period: February 3, 2022 – February 13, 2024Lead...
...Investors That Class Action Lawsuits Have Been Filed Against Biogen, Charge, and Fastly and...
Benzinga· 6 days agoBragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Biogen
Biogen Inc. Securities Fraud Class Action Lawsuit Pending: Contact The Gross Law Firm Before July...
Morningstar· 5 days agoNEW YORK , June 20, 2024 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Biogen Inc. (NASDAQ: BIIB). Shareholders who purchased shares of BIIB during the class period listed are encouraged
New drug’s potentially fatal side effects obscured by ‘soothing acronym,’ doctors say
The Columbian· 2 days agoSeventy-nine-year-old Genevieve Lane volunteered to take the Alzheimer’s drug Leqembi in a clinical trial because she was forgetting words and misplacing her keys. Infusions of the drug gave ...
Biogen Inc. (BIIB) is a Top-Ranked Momentum Stock: Should You Buy?
Zacks· 2 days agoTaking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both. The research service ...
BIIB Investors Have Opportunity to lead Biogen Inc. Securities Fraud Lawsuit
Morningstar· 5 days agoLOS ANGELES, June 20, 2024 /PRNewswire/ -- , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Biogen Inc. ("Biogen ...
Eli Lilly Has a New Drug That Could Push the Stock Higher
Motley Fool via Yahoo Finance· 5 days agoExperts estimate that the market will grow by 20% annually from 2023 to 2030. Lilly's main...
Is Eli Lilly (LLY) a Buy on Tirzepatide Success in Sleep Apnea?
Zacks via Yahoo Finance· 8 hours agoEli Lilly (LLY) files for the approval of tirzepatide to treat obstructive sleep apnea in adults...
Is Eli Lilly Stock A Buy After FDA Advisors Back Its Alzheimer's Drug?
Investor's Business Daily· 5 days agoDonanemab works by removing build-up plaque in the brain, known as amyloid beta. Doing so can cause...
Ionis (IONS) Expands Licensing Deal With Otsuka for HAE Drug
Zacks via Yahoo Finance· 6 days agoIonis (IONS) out-licenses the rights for its HAE drug to Otsuka in the Asia-Pacific region. The...